 | • レポートコード：MRC2-11QY12502 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は白血病スクリーニングのグローバル市場について調査・分析したレポートです。種類別（骨髄穿刺・生検、胸部X線/胸部CATスキャン、脊椎穿刺）市場規模、用途別（がん研究センター、診断研究所、クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別白血病スクリーニングの競争状況、市場シェア ・世界の白血病スクリーニング市場：種類別市場規模 2015年-2020年（骨髄穿刺・生検、胸部X線/胸部CATスキャン、脊椎穿刺） ・世界の白血病スクリーニング市場：種類別市場規模予測 2021年-2026年（骨髄穿刺・生検、胸部X線/胸部CATスキャン、脊椎穿刺） ・世界の白血病スクリーニング市場：用途別市場規模 2015年-2020年（がん研究センター、診断研究所、クリニック、病院） ・世界の白血病スクリーニング市場：用途別市場規模予測 2021年-2026年（がん研究センター、診断研究所、クリニック、病院） ・北米の白血病スクリーニング市場分析：米国、カナダ ・ヨーロッパの白血病スクリーニング市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの白血病スクリーニング市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の白血病スクリーニング市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの白血病スクリーニング市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Abbvie、GE Healthcare、Siemens Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical Systems、Varian Medical Systems、Shimadzu Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Currently, there are no standard leukemia screening methods recommended for regularly testing the leukemia affected patients. Specifically, no leukemia screening test has been reliably confirmed enough to detect the cancer in its early stages before the development of symptoms. Research and development for the leukemia screening is going on, and there is still much to be known about the exact causes of leukemia. As the understanding continues to increase, scientists are gaining a greater knowledge of possible ways to prevent, screen and treat this condition.
Leukemia is commonly caused because of the exposure to radiations, changing lifestyle, genetic mutations, and environmental conditions. Leukemia cases are more commonly found in adults and are observed to develop with aging. Thus, increasing aging population and high occurrence of leukemia are the factors rising the leukemia screening market. Also, novel advancements and R&D in the oncology sector and growing number of biotechnology companies, may also expected to boost the market growth.
Market Analysis and Insights: Global Leukemia Screening Market
The global Leukemia Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Leukemia Screening Scope and Market Size
Leukemia Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Abbvie
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical Systems
Varian Medical Systems
Shimadzu Corporation
Market segment by Type, the product can be split into
Bone Marrow Aspiration and Biopsy
Chest X-Ray or Chest CAT Scan
Spinal Tap
Market segment by Application, split into
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Leukemia Screening Revenue
1.4 Market by Type
1.4.1 Global Leukemia Screening Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bone Marrow Aspiration and Biopsy
1.4.3 Chest X-Ray or Chest CAT Scan
1.4.4 Spinal Tap
1.5 Market by Application
1.5.1 Global Leukemia Screening Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Screening Market Perspective (2015-2026)
2.2 Global Leukemia Screening Growth Trends by Regions
2.2.1 Leukemia Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Leukemia Screening Historic Market Share by Regions (2015-2020)
2.2.3 Leukemia Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Leukemia Screening Market Growth Strategy
2.3.6 Primary Interviews with Key Leukemia Screening Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Screening Players by Market Size
3.1.1 Global Top Leukemia Screening Players by Revenue (2015-2020)
3.1.2 Global Leukemia Screening Revenue Market Share by Players (2015-2020)
3.1.3 Global Leukemia Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Leukemia Screening Market Concentration Ratio
3.2.1 Global Leukemia Screening Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Leukemia Screening Revenue in 2019
3.3 Leukemia Screening Key Players Head office and Area Served
3.4 Key Players Leukemia Screening Product Solution and Service
3.5 Date of Enter into Leukemia Screening Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Leukemia Screening Historic Market Size by Type (2015-2020)
4.2 Global Leukemia Screening Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Leukemia Screening Market Size by Application (2015-2020)
5.2 Global Leukemia Screening Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Leukemia Screening Market Size (2015-2020)
6.2 Leukemia Screening Key Players in North America (2019-2020)
6.3 North America Leukemia Screening Market Size by Type (2015-2020)
6.4 North America Leukemia Screening Market Size by Application (2015-2020)
7 Europe
7.1 Europe Leukemia Screening Market Size (2015-2020)
7.2 Leukemia Screening Key Players in Europe (2019-2020)
7.3 Europe Leukemia Screening Market Size by Type (2015-2020)
7.4 Europe Leukemia Screening Market Size by Application (2015-2020)
8 China
8.1 China Leukemia Screening Market Size (2015-2020)
8.2 Leukemia Screening Key Players in China (2019-2020)
8.3 China Leukemia Screening Market Size by Type (2015-2020)
8.4 China Leukemia Screening Market Size by Application (2015-2020)
9 Japan
9.1 Japan Leukemia Screening Market Size (2015-2020)
9.2 Leukemia Screening Key Players in Japan (2019-2020)
9.3 Japan Leukemia Screening Market Size by Type (2015-2020)
9.4 Japan Leukemia Screening Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Leukemia Screening Market Size (2015-2020)
10.2 Leukemia Screening Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Leukemia Screening Market Size by Type (2015-2020)
10.4 Southeast Asia Leukemia Screening Market Size by Application (2015-2020)
11 India
11.1 India Leukemia Screening Market Size (2015-2020)
11.2 Leukemia Screening Key Players in India (2019-2020)
11.3 India Leukemia Screening Market Size by Type (2015-2020)
11.4 India Leukemia Screening Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Leukemia Screening Market Size (2015-2020)
12.2 Leukemia Screening Key Players in Central & South America (2019-2020)
12.3 Central & South America Leukemia Screening Market Size by Type (2015-2020)
12.4 Central & South America Leukemia Screening Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Leukemia Screening Introduction
13.1.4 Abbott Revenue in Leukemia Screening Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Abbvie
13.2.1 Abbvie Company Details
13.2.2 Abbvie Business Overview
13.2.3 Abbvie Leukemia Screening Introduction
13.2.4 Abbvie Revenue in Leukemia Screening Business (2015-2020)
13.2.5 Abbvie Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview
13.3.3 GE Healthcare Leukemia Screening Introduction
13.3.4 GE Healthcare Revenue in Leukemia Screening Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Details
13.4.2 Siemens Healthcare Business Overview
13.4.3 Siemens Healthcare Leukemia Screening Introduction
13.4.4 Siemens Healthcare Revenue in Leukemia Screening Business (2015-2020)
13.4.5 Siemens Healthcare Recent Development
13.5 Philips Healthcare
13.5.1 Philips Healthcare Company Details
13.5.2 Philips Healthcare Business Overview
13.5.3 Philips Healthcare Leukemia Screening Introduction
13.5.4 Philips Healthcare Revenue in Leukemia Screening Business (2015-2020)
13.5.5 Philips Healthcare Recent Development
13.6 Canon Medical Systems
13.6.1 Canon Medical Systems Company Details
13.6.2 Canon Medical Systems Business Overview
13.6.3 Canon Medical Systems Leukemia Screening Introduction
13.6.4 Canon Medical Systems Revenue in Leukemia Screening Business (2015-2020)
13.6.5 Canon Medical Systems Recent Development
13.7 Hitachi Medical Systems
13.7.1 Hitachi Medical Systems Company Details
13.7.2 Hitachi Medical Systems Business Overview
13.7.3 Hitachi Medical Systems Leukemia Screening Introduction
13.7.4 Hitachi Medical Systems Revenue in Leukemia Screening Business (2015-2020)
13.7.5 Hitachi Medical Systems Recent Development
13.8 Varian Medical Systems
13.8.1 Varian Medical Systems Company Details
13.8.2 Varian Medical Systems Business Overview
13.8.3 Varian Medical Systems Leukemia Screening Introduction
13.8.4 Varian Medical Systems Revenue in Leukemia Screening Business (2015-2020)
13.8.5 Varian Medical Systems Recent Development
13.9 Shimadzu Corporation
13.9.1 Shimadzu Corporation Company Details
13.9.2 Shimadzu Corporation Business Overview
13.9.3 Shimadzu Corporation Leukemia Screening Introduction
13.9.4 Shimadzu Corporation Revenue in Leukemia Screening Business (2015-2020)
13.9.5 Shimadzu Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Leukemia Screening Key Market Segments
Table 2. Key Players Covered: Ranking by Leukemia Screening Revenue
Table 3. Ranking of Global Top Leukemia Screening Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Leukemia Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bone Marrow Aspiration and Biopsy
Table 6. Key Players of Chest X-Ray or Chest CAT Scan
Table 7. Key Players of Spinal Tap
Table 8. Global Leukemia Screening Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Leukemia Screening Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Leukemia Screening Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Leukemia Screening Market Share by Regions (2015-2020)
Table 12. Global Leukemia Screening Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Leukemia Screening Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Leukemia Screening Market Growth Strategy
Table 18. Main Points Interviewed from Key Leukemia Screening Players
Table 19. Global Leukemia Screening Revenue by Players (2015-2020) (Million US$)
Table 20. Global Leukemia Screening Market Share by Players (2015-2020)
Table 21. Global Top Leukemia Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Screening as of 2019)
Table 22. Global Leukemia Screening by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Leukemia Screening Product Solution and Service
Table 25. Date of Enter into Leukemia Screening Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 28. Global Leukemia Screening Market Size Share by Type (2015-2020)
Table 29. Global Leukemia Screening Revenue Market Share by Type (2021-2026)
Table 30. Global Leukemia Screening Market Size Share by Application (2015-2020)
Table 31. Global Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 32. Global Leukemia Screening Market Size Share by Application (2021-2026)
Table 33. North America Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Leukemia Screening Market Share (2019-2020)
Table 35. North America Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 36. North America Leukemia Screening Market Share by Type (2015-2020)
Table 37. North America Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 38. North America Leukemia Screening Market Share by Application (2015-2020)
Table 39. Europe Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Leukemia Screening Market Share (2019-2020)
Table 41. Europe Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Leukemia Screening Market Share by Type (2015-2020)
Table 43. Europe Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Leukemia Screening Market Share by Application (2015-2020)
Table 45. China Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 46. China Key Players Leukemia Screening Market Share (2019-2020)
Table 47. China Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 48. China Leukemia Screening Market Share by Type (2015-2020)
Table 49. China Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 50. China Leukemia Screening Market Share by Application (2015-2020)
Table 51. Japan Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Leukemia Screening Market Share (2019-2020)
Table 53. Japan Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Leukemia Screening Market Share by Type (2015-2020)
Table 55. Japan Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Leukemia Screening Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Leukemia Screening Market Share (2019-2020)
Table 59. Southeast Asia Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Leukemia Screening Market Share by Type (2015-2020)
Table 61. Southeast Asia Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Leukemia Screening Market Share by Application (2015-2020)
Table 63. India Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 64. India Key Players Leukemia Screening Market Share (2019-2020)
Table 65. India Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 66. India Leukemia Screening Market Share by Type (2015-2020)
Table 67. India Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 68. India Leukemia Screening Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Leukemia Screening Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Leukemia Screening Market Share (2019-2020)
Table 71. Central & South America Leukemia Screening Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Leukemia Screening Market Share by Type (2015-2020)
Table 73. Central & South America Leukemia Screening Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Leukemia Screening Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Abbvie Company Details
Table 81. Abbvie Business Overview
Table 82. Abbvie Product
Table 83. Abbvie Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 84. Abbvie Recent Development
Table 85. GE Healthcare Company Details
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Product
Table 88. GE Healthcare Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 89. GE Healthcare Recent Development
Table 90. Siemens Healthcare Company Details
Table 91. Siemens Healthcare Business Overview
Table 92. Siemens Healthcare Product
Table 93. Siemens Healthcare Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 94. Siemens Healthcare Recent Development
Table 95. Philips Healthcare Company Details
Table 96. Philips Healthcare Business Overview
Table 97. Philips Healthcare Product
Table 98. Philips Healthcare Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 99. Philips Healthcare Recent Development
Table 100. Canon Medical Systems Company Details
Table 101. Canon Medical Systems Business Overview
Table 102. Canon Medical Systems Product
Table 103. Canon Medical Systems Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 104. Canon Medical Systems Recent Development
Table 105. Hitachi Medical Systems Company Details
Table 106. Hitachi Medical Systems Business Overview
Table 107. Hitachi Medical Systems Product
Table 108. Hitachi Medical Systems Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 109. Hitachi Medical Systems Recent Development
Table 110. Varian Medical Systems Business Overview
Table 111. Varian Medical Systems Product
Table 112. Varian Medical Systems Company Details
Table 113. Varian Medical Systems Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 114. Varian Medical Systems Recent Development
Table 115. Shimadzu Corporation Company Details
Table 116. Shimadzu Corporation Business Overview
Table 117. Shimadzu Corporation Product
Table 118. Shimadzu Corporation Revenue in Leukemia Screening Business (2015-2020) (Million US$)
Table 119. Shimadzu Corporation Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Screening Market Share by Type: 2020 VS 2026
Figure 2. Bone Marrow Aspiration and Biopsy Features
Figure 3. Chest X-Ray or Chest CAT Scan Features
Figure 4. Spinal Tap Features
Figure 5. Global Leukemia Screening Market Share by Application: 2020 VS 2026
Figure 6. Cancer Research Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Leukemia Screening Report Years Considered
Figure 11. Global Leukemia Screening Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Leukemia Screening Market Share by Regions: 2020 VS 2026
Figure 13. Global Leukemia Screening Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Leukemia Screening Market Share by Players in 2019
Figure 16. Global Top Leukemia Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Screening as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Leukemia Screening Revenue in 2019
Figure 18. North America Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Leukemia Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
骨髄穿刺・生検の世界市場（～2026年） Market Analysis and Insights: Global Bone Marrow Aspiration and Biopsy Market The global Bone Marrow Aspiration and Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bone Marrow Aspiration and Biopsy Scope and Mar…- がん検診/スクリーニングの世界市場（～2026年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…
- 子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 前立腺がんスクリーニングの世界市場（～2026年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- 聴覚スクリーニング・診断装置の世界市場（～2026年） The hearing screener device has low sensitivity in detecting the presence of possible hearing loss in children when used in the school setting. Thus, the hearing screener device is not an ideal tool to use in the mass hearing screening of children in the school setting where there are no soundproof …